Review





Similar Products

human primary lung fibroblasts  (ATCC)
95
ATCC human primary lung fibroblasts
Human Primary Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human primary lung fibroblasts/product/ATCC
Average 95 stars, based on 1 article reviews
human primary lung fibroblasts - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
primary human lung fibroblasts  (ATCC)
94
ATCC primary human lung fibroblasts
Primary Human Lung Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human lung fibroblasts/product/ATCC
Average 94 stars, based on 1 article reviews
primary human lung fibroblasts - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
msc supplement  (ATCC)
94
ATCC msc supplement
Msc Supplement, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msc supplement/product/ATCC
Average 94 stars, based on 1 article reviews
msc supplement - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
l alanyl l glutamine  (ATCC)
94
ATCC l alanyl l glutamine
L Alanyl L Glutamine, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/l alanyl l glutamine/product/ATCC
Average 94 stars, based on 1 article reviews
l alanyl l glutamine - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
primary human lung mrc 5 fibroblasts  (ATCC)
99
ATCC primary human lung mrc 5 fibroblasts
USP1 restricts CMV <t>replication.</t> <t>MRC-5</t> fibroblasts were reverse-transfected with a siRNA pool targeting UAF1 or USP1 or an NTC. At two days post-transfection, cells were infected with CMV TB40/E-GFP wild-type (WT) or TB40/E-∆ UL138 STOP at an MOI of 1 and cells were harvested at 96 hpi. ( A ) Viral genome copy number was determined by qPCR using a TB40/E BAC standard curve and primer set designed for the region of the viral genome encoding the β2.7 transcript. The graph represents the fold change in viral genome copy number relative to siNTC. ( B ) Virus yields were measured by TCID 50 and normalized relative to the WT siNTC condition. For panels (A) and (B), statistical significance was determined by two-way ANOVA with Dunnett’s multiple comparisons test. Asterisks (** P < .01, *** P < .001, **** P < .0001) represent statistically significant differences determined for four independent experiments. ns, nonsignificant. ( C ) Whole cell lysates were collected at two days post-transfection to determine efficiency of USP1 knockdown by immunoblotting using monoclonal antibodies for USP1 and tubulin as a loading control and secondary antibodies conjugated to DyLight™ 680 (mouse) or 800 (rabbit). Densitometry analysis of three biological replicates reveals an average 68% knockdown compared to siNTC. ( D ) At two days post-transfection, RNA was collected for RT-qPCR to determine the efficiency of UAF1 knockdown relative to siNTC. H6PD was used as a housekeeping control for cell number. Over all experiments, an average knockdown efficiency of 81% was achieved. A paired t- test was used to determine statistical significance, **** P < .0001, over multiple independent experiments.
Primary Human Lung Mrc 5 Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human lung mrc 5 fibroblasts/product/ATCC
Average 99 stars, based on 1 article reviews
primary human lung mrc 5 fibroblasts - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
human lung fibroblast hfl cells  (ATCC)
97
ATCC human lung fibroblast hfl cells
USP1 restricts CMV <t>replication.</t> <t>MRC-5</t> fibroblasts were reverse-transfected with a siRNA pool targeting UAF1 or USP1 or an NTC. At two days post-transfection, cells were infected with CMV TB40/E-GFP wild-type (WT) or TB40/E-∆ UL138 STOP at an MOI of 1 and cells were harvested at 96 hpi. ( A ) Viral genome copy number was determined by qPCR using a TB40/E BAC standard curve and primer set designed for the region of the viral genome encoding the β2.7 transcript. The graph represents the fold change in viral genome copy number relative to siNTC. ( B ) Virus yields were measured by TCID 50 and normalized relative to the WT siNTC condition. For panels (A) and (B), statistical significance was determined by two-way ANOVA with Dunnett’s multiple comparisons test. Asterisks (** P < .01, *** P < .001, **** P < .0001) represent statistically significant differences determined for four independent experiments. ns, nonsignificant. ( C ) Whole cell lysates were collected at two days post-transfection to determine efficiency of USP1 knockdown by immunoblotting using monoclonal antibodies for USP1 and tubulin as a loading control and secondary antibodies conjugated to DyLight™ 680 (mouse) or 800 (rabbit). Densitometry analysis of three biological replicates reveals an average 68% knockdown compared to siNTC. ( D ) At two days post-transfection, RNA was collected for RT-qPCR to determine the efficiency of UAF1 knockdown relative to siNTC. H6PD was used as a housekeeping control for cell number. Over all experiments, an average knockdown efficiency of 81% was achieved. A paired t- test was used to determine statistical significance, **** P < .0001, over multiple independent experiments.
Human Lung Fibroblast Hfl Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung fibroblast hfl cells/product/ATCC
Average 97 stars, based on 1 article reviews
human lung fibroblast hfl cells - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier
human lung cancer  (ATCC)
99
ATCC human lung cancer
USP1 restricts CMV <t>replication.</t> <t>MRC-5</t> fibroblasts were reverse-transfected with a siRNA pool targeting UAF1 or USP1 or an NTC. At two days post-transfection, cells were infected with CMV TB40/E-GFP wild-type (WT) or TB40/E-∆ UL138 STOP at an MOI of 1 and cells were harvested at 96 hpi. ( A ) Viral genome copy number was determined by qPCR using a TB40/E BAC standard curve and primer set designed for the region of the viral genome encoding the β2.7 transcript. The graph represents the fold change in viral genome copy number relative to siNTC. ( B ) Virus yields were measured by TCID 50 and normalized relative to the WT siNTC condition. For panels (A) and (B), statistical significance was determined by two-way ANOVA with Dunnett’s multiple comparisons test. Asterisks (** P < .01, *** P < .001, **** P < .0001) represent statistically significant differences determined for four independent experiments. ns, nonsignificant. ( C ) Whole cell lysates were collected at two days post-transfection to determine efficiency of USP1 knockdown by immunoblotting using monoclonal antibodies for USP1 and tubulin as a loading control and secondary antibodies conjugated to DyLight™ 680 (mouse) or 800 (rabbit). Densitometry analysis of three biological replicates reveals an average 68% knockdown compared to siNTC. ( D ) At two days post-transfection, RNA was collected for RT-qPCR to determine the efficiency of UAF1 knockdown relative to siNTC. H6PD was used as a housekeeping control for cell number. Over all experiments, an average knockdown efficiency of 81% was achieved. A paired t- test was used to determine statistical significance, **** P < .0001, over multiple independent experiments.
Human Lung Cancer, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung cancer/product/ATCC
Average 99 stars, based on 1 article reviews
human lung cancer - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


USP1 restricts CMV replication. MRC-5 fibroblasts were reverse-transfected with a siRNA pool targeting UAF1 or USP1 or an NTC. At two days post-transfection, cells were infected with CMV TB40/E-GFP wild-type (WT) or TB40/E-∆ UL138 STOP at an MOI of 1 and cells were harvested at 96 hpi. ( A ) Viral genome copy number was determined by qPCR using a TB40/E BAC standard curve and primer set designed for the region of the viral genome encoding the β2.7 transcript. The graph represents the fold change in viral genome copy number relative to siNTC. ( B ) Virus yields were measured by TCID 50 and normalized relative to the WT siNTC condition. For panels (A) and (B), statistical significance was determined by two-way ANOVA with Dunnett’s multiple comparisons test. Asterisks (** P < .01, *** P < .001, **** P < .0001) represent statistically significant differences determined for four independent experiments. ns, nonsignificant. ( C ) Whole cell lysates were collected at two days post-transfection to determine efficiency of USP1 knockdown by immunoblotting using monoclonal antibodies for USP1 and tubulin as a loading control and secondary antibodies conjugated to DyLight™ 680 (mouse) or 800 (rabbit). Densitometry analysis of three biological replicates reveals an average 68% knockdown compared to siNTC. ( D ) At two days post-transfection, RNA was collected for RT-qPCR to determine the efficiency of UAF1 knockdown relative to siNTC. H6PD was used as a housekeeping control for cell number. Over all experiments, an average knockdown efficiency of 81% was achieved. A paired t- test was used to determine statistical significance, **** P < .0001, over multiple independent experiments.

Journal: Nucleic Acids Research

Article Title: Human cytomegalovirus regulates host DNA repair machinery for viral genome integrity

doi: 10.1093/nar/gkaf1445

Figure Lengend Snippet: USP1 restricts CMV replication. MRC-5 fibroblasts were reverse-transfected with a siRNA pool targeting UAF1 or USP1 or an NTC. At two days post-transfection, cells were infected with CMV TB40/E-GFP wild-type (WT) or TB40/E-∆ UL138 STOP at an MOI of 1 and cells were harvested at 96 hpi. ( A ) Viral genome copy number was determined by qPCR using a TB40/E BAC standard curve and primer set designed for the region of the viral genome encoding the β2.7 transcript. The graph represents the fold change in viral genome copy number relative to siNTC. ( B ) Virus yields were measured by TCID 50 and normalized relative to the WT siNTC condition. For panels (A) and (B), statistical significance was determined by two-way ANOVA with Dunnett’s multiple comparisons test. Asterisks (** P < .01, *** P < .001, **** P < .0001) represent statistically significant differences determined for four independent experiments. ns, nonsignificant. ( C ) Whole cell lysates were collected at two days post-transfection to determine efficiency of USP1 knockdown by immunoblotting using monoclonal antibodies for USP1 and tubulin as a loading control and secondary antibodies conjugated to DyLight™ 680 (mouse) or 800 (rabbit). Densitometry analysis of three biological replicates reveals an average 68% knockdown compared to siNTC. ( D ) At two days post-transfection, RNA was collected for RT-qPCR to determine the efficiency of UAF1 knockdown relative to siNTC. H6PD was used as a housekeeping control for cell number. Over all experiments, an average knockdown efficiency of 81% was achieved. A paired t- test was used to determine statistical significance, **** P < .0001, over multiple independent experiments.

Article Snippet: Primary human lung MRC-5 fibroblasts (ATCC CCL-171) were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 10 mM HEPES, 1 mM sodium pyruvate, 2 mM l -alanyl-glutamine, 0.1 mM nonessential amino acids, 100 U/ml penicillin, and 100 μg/ml streptomycin.

Techniques: Transfection, Infection, Virus, Knockdown, Western Blot, Bioprocessing, Control, Quantitative RT-PCR